P/E (MRFY) | Fwd. P/E (12 Mo.) | PEG | 1 Yr. EPS Growth Rate | |
---|---|---|---|---|
GERN | N/A | N/A | N/A | -27.21% |
GERN Peer | N/A | N/A | N/A | +51.81% |
Biotechnology Industry | 14.4 | 17.0 | 0.4 | -141.75% |
Health Technology Sector | 35.6 | 25.7 | 0.5 | +6.08% |
S&P 500 Market | 36.1 | 64.6 | 1.2 | +98.97% |
Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
---|---|---|---|---|
Mean Estimate | -$0.10 | -$0.12 | -$0.11 | -$0.11 |
Previous Mean | -$0.10 | -$0.12 | -$0.11 | -$0.11 |
Standard Deviation | 0.01 | 0.03 | 0.04 | 0.04 |
Low Estimate | -$0.11 | -$0.15 | -$0.13 | -$0.13 |
High Estimate | -$0.08 | -$0.08 | -$0.08 | -$0.08 |